- ￥3200 - 13600
- Bioss
- BIO0217SM
- 2025年10月10日
- 产品信息以Bioss网站为准
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 应用范围：
产品信息以Bioss网站为准
- 规格：
1mg/5mg/20mg
| 规格： | 1mg | 产品价格： | ￥3200.0 |
|---|---|---|---|
| 规格： | 5mg | 产品价格： | ￥7400.0 |
| 规格： | 20mg | 产品价格： | ￥13600.0 |
| 产品编号 | BIO0217SM |
| 英文名称 | Anti-human LAG3 / CD223 (Relatlimab Biosimilar) |
| 产品应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo Not yet tested in other applications. |
| 交叉反应 | Human, Cynomolgus |
| 亚型 | Human IgG4SP |
| 性状 | Lyophilized |
| 纯化方法 | Protein A |
| 克隆类型 | Monoclonal |
| 理论分子量 | 145.58 kDa |
| 保存条件 | For long term storage, the produce should be stored at -20°C or lower. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 应用 | 推荐稀释比例 |
Anti-LAG3 / CD223 Reference Antibody (relatlimab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-LAG3 / CD223 Reference Antibody (relatlimab) is 100%, determined by SEC-HPLC.
Immobilized human LAG3 His at 2 ug/mL can bind Anti-LAG3 / CD223 Reference Antibody (relatlimab), EC50=0.02812 ug/mL.
Human LAG3 CHO cells were stained with Anti-LAG3 / CD223 Reference Antibody (relatlimab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.5464 ug/mL.
Relatlimab inhibited the tumor growth of MC38 on Human LAG3 mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 53.8% at 10 mpk at D28.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
Anti-human LAG3 / CD223 (Relatlimab Biosimilar)(BIO0217SM)-1mg/5mg/20mg
￥3200 - 13600
